Global Biosensors Market to Reach $34.4 Billion by 2025, Growing at a 9.6% CAGR

Global biosensors market was valued at $34.4 billion in 2025 and is growing at a CAGR of 9.6% during the forecast period (2026-2035). Technological advancements in biosensing increasingly focus on multi-molecule detection platforms, enabling the simultaneous and continuous monitoring of multiple biomarkers in real time. These platforms improve diagnostic depth and support more comprehensive physiological insights compared to single-analyte sensors. Market growth is further driven by sensor miniaturization, which allows minimally invasive or pain-free applications, along with AI-enabled analytics that enhance data interpretation, trend prediction, and clinical relevance. In parallel, smartphone integration has become a critical enabler, improving device accessibility, user engagement, and real-time data transmission within digital health ecosystems.

Browse the full report description of “Biosensors Market Size, Share & Trends Analysis By Product Type (Wearable biosensors, and Non?wearable biosensors ), By Technology (Electrochemical, Optical, Thermal, Piezoelectric, and Nanomechanical), By Application (Medical diagnostics, Environmental monitoring, Food & beverage Testing/Food Toxicity, Agriculture, Bioprocess/bioreactor monitoring, Security & biodefense, and Others) By End-User (Point-of-care (PoC) testing, Home healthcare diagnostics, Research laboratories / R&D, Food industry, Security / Biodefense, and Others), Forecast Period (2026-2035)” of https://www.omrglobal.com/industry-reports/biosensors-market

Additionally, these technological trends are accelerating investment activity, regulatory progress, and commercialization efforts across the wearable biosensors segment, particularly for continuous monitoring applications in metabolic and chronic disease management. For instance, In July 2025, Sava Technologies secured $19 million in a Series A financing round aimed at enhancing its wearable biosensor technology. The funds will expedite regulatory approval and commercialization efforts for a next-generation wearable device, expand its team of over 60 employees, and boost automated manufacturing capabilities while advancing clinical validation. The company creates a multi-molecule biosensor that detects biomarkers just under the skin in real-time, with its inaugural product being a pain-free continuous glucose monitor (CGM) that transmits molecular insights to users' phones.

Key Innovators Driving Biosensors Transformation

The key players in the Biosensors market include Abbott Laboratories, Dexcom, Hoffmann-La Roche Ltd., Medtronic Plc, Siemens Healthineers, among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

• In April 2025, Biosensor tech company Biolinq secured a $100 million Series C financing round led by Alpha Wave Ventures, with support from existing investors including RiverVest Venture Partners and AXA IM Alts. The funding will aid Biolinq in obtaining US regulatory approval for its first product, an autonomous intradermal glucose sensor that continuously measures glucose levels via small electrochemical sensors worn beneath the skin.
• In April 2024, Biolinq successfully raised $58 million for its development of precision multi-analyte wearable biosensors aimed at improving metabolic health. The funding round included significant contributions from existing investors such as AXA IM Alts and Taisho Pharmaceutical. The company focuses on a wearable patch that monitors glucose levels through small electrochemical sensors located in the intradermal space. The raised funds will be allocated to conducting a clinical trial for its glucose sensor and preparing for FDA submission.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product
  • By Technology
  • By Application
  • By End-User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Abbott Laboratories, Dexcom, Hoffmann-La Roche Ltd., Medtronic Plc, Siemens Healthineers, among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Biosensors Market Report Segment

By Product

• Wearable biosensors
• Non-wearable biosensors

By Technology

• Electrochemical
• Optical
• Thermal
• Piezoelectric
• Nanomechanical

By Application

• Medical diagnostics
• Environmental monitoring
• Food & beverage testing/food toxicity
• Agriculture
• Bioprocess/bioreactor monitoring
• Security & biodefense
• Others

By End-User

• Point-of-care (PoC) testing
• Home healthcare diagnostics
• Research laboratories / R&D
• Food industry
• Security / Biodefense
• Others

Global Biosensors Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biosensors-market